Greg Licholai, Contributor

Author's posts

Digital Medicine And Remote Monitoring Receives Boost From New Playbook

A new Digital Measures Playbook was recently unveiled to help doctors and companies develop safe and effective clinical measures across clinical research, patient care and public health.

Bedside MRI Receives Clearance

A new portable Magnetic Resonance Imaging (MRI) system recently received clearance by the US Food and Drug Administration (FDA).

Fitbit Atrial Fibrillation Approval Revs Up Competition With Apple Watch

Fitbit announced this week regulatory clearance in both the US and Europe for its electrocardiogram (ECG) app to identify atrial fibrillation (AFib).

Johnson & Johnson, Apple’s New Virtual Trial Model Shows Early Enrollment Success

Johnson & Johnson and Apple launched first-of-its-kind virtual clinical trial and is already enrolling patients dramatically faster than standard studies.

Digital Therapeutics Leaders Focus On Reimbursement

CEOs at Digital Therapeutics West conference discuss payment models

Digital Healthcare Growth Drivers In 2020

Digital transformation of healthcare drivers include AI and virtual trials to empower patient outcomes, funding from public markets, regulatory innovation, and corporate alliances

Digital Health Trial Uses AI For Better Epilepsy Treatment Decisions

Digital trial using artificial intelligence for epilepsy sponsored by Stanford and doc.ai analyzes vast amounts of data

AI Policies Are Setting Stage To Transform Healthcare But More Is Needed

AI Executive Initiative has started flow of funds and agency proposals that will lead to more accurate diagnoses, earlier treatments and ultimately empower patients be in control of their own health

Digital Medicine Movement Is Growing Up And That’s A Good Thing

As digital medicine matures industry professionals are collaborating to create best practices and validate business models.

Digital Therapeutics Hot Summer With Major IPOs and First Oncology App

Voluntis announced marketing authorization of the first oncology disease management software platform, and two digital health companies Livongo and Health Catalyst had IPOs with multi-billion dollar valuations this summer.